Management of Post-MVA Headache with Benign Initial Imaging
Initial Clinical Assessment
- The American Family Physician recommends monitoring closely for red flag symptoms, such as progressive worsening of headache severity or frequency, new focal neurological deficits, change in headache pattern, altered mental status, severe refractory headache, and orthostatic features, which would necessitate repeat neuroimaging 1
Management Approach
- The American Family Physician suggests that for acute headache management, NSAIDs or acetaminophen can be used for mild-moderate pain, and it is essential to avoid medication overuse by limiting simple analgesics/NSAIDs to <15 days per month to prevent medication overuse headache 2
- The American Academy of Family Physicians recommends having the patient track frequency, severity, characteristics, and medication use with a headache diary, and scheduling reassessment within 2-4 weeks to evaluate progression 2
- The American Family Physician advises instructing the patient to seek immediate evaluation if any red flag symptoms develop, such as severe refractory headache not responding to appropriate medical management 1
Monitoring Strategy
- The American Academy of Family Physicians suggests that repeat neuroimaging (MRI brain preferred over CT) is indicated if headaches are progressively worsening despite appropriate management, new or unexplained neurological findings emerge on examination, headache pattern changes significantly from initial presentation, or patient develops severe refractory headache not responding to treatment 3
Common Pitfalls to Avoid
- The American Academy of Family Physicians recommends against over-imaging stable patients, as the rate of finding serious intracranial abnormalities is only 0.5% in patients with chronic headache and normal neurological examination, comparable to incidental findings in asymptomatic volunteers 3
Prophylactic Therapy Consideration
- The American Academy of Family Physicians suggests considering prophylactic therapy with topiramate as first-line agent if headaches persist beyond 4-6 weeks and meet criteria for chronic post-traumatic headache (≥15 days per month) 2